...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Bisphosphonate sequestering agents. Synthesis and preliminary evaluation for in vitro and in vivo uranium(VI) chelation.
【24h】

Bisphosphonate sequestering agents. Synthesis and preliminary evaluation for in vitro and in vivo uranium(VI) chelation.

机译:双膦酸酯螯合剂。体外和体内铀(VI)螯合的合成和初步评估。

获取原文
获取原文并翻译 | 示例
           

摘要

A library of bisphosphonate-based ligands was prepared using solution-phase parallel synthesis and tested for its uranium-binding properties. With the help of a screening method, based on a chromophoric complex displacement procedure, 23 dipodal and tripodal chelates bearing bisphosphonate chelating functions were found to display very high affinity for the uranyl ion and were selected for evaluation of their in vivo uranyl-removal efficacy. Among them, 11 ligands induced a huge modification of the uranyl biodistribution by deviating the metal from kidney and bones to liver. Among the other ligands, the most potent was the dipodal bisphosphonate 3C which reduced the retention of uranyl and increased its excretion by around 10% of the injected metal.
机译:使用溶液相平行合成方法制备了基于双膦酸酯的配体库,并对其铀结合性能进行了测试。借助筛选方法,基于发色团复杂的置换程序,发现具有双膦酸酯螯合功能的23个二脚体和三脚体螯合物显示出对铀酰离子的极高亲和力,并被选择用于评估其体内去除铀酰的功效。其中11种配体通过将金属从肾脏和骨骼转移到肝脏而引起了铀酰生物分布的巨大改变。在其他配体中,最有效的是二足双膦酸酯3C,它降低了铀酰的保留率,并且其排泄量增加了所注入金属的10%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号